Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series
January 15, 2019 09:05 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of...
Update: Adial Pharmaceuticals to Present at The 2019 Wall Street Conference
January 10, 2019 10:24 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals to Present at The 2019 Wall Street Conference
January 10, 2019 08:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Retires All Outstanding Debt
December 24, 2018 08:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 24, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL;ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Announces Amendment to License Agreement with the University of Virginia Licensing & Ventures Group
December 19, 2018 09:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Announces Planned Expansion of Lead Asset AD04 into Opioid Addiction Including Synthetic Opioids Such as Fentanyl
December 13, 2018 08:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Announces Professor Hannu Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki, Finland as Coordinating Principal Investigator for Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use Disorder
December 10, 2018 08:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com a clinical-stage biopharmaceutical company focused on the development of...
Adial Pharmaceuticals Establishes Scientific Advisory Board and Appoints Global Thought Leader in the Field of Alcohol Use Disorder
November 29, 2018 09:10 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development...
Adial Pharmaceuticals Chairman Featured in Doctors Channel Video Discussing Alcohol Use Disorder
November 21, 2018 08:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...
Adial Pharmaceuticals Engages CRO to Begin Phase 3 Clinical Trials of AD04 for the Treatment of Alcohol Use Disorder
November 19, 2018 08:00 ET
|
Adial Pharmaceuticals, Inc.
CHARLOTTESVILLE, Va., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...